Hot Deals:
a v thomas 11,770.00 (-0.25 %) adtech 29.00 (-3.33 %) amol minechem 620.00 (1.64 %) anand i-power 20.00 anglo french 370.00 (-2.37 %) aricent 575.00 (0.88 %) arkfin investments 50.00 arohan 181.00 (0.56 %) assam carbon 227.00 (-1.30 %) associated pigments 42.00 (-4.55 %) atlas copco 9,100.00 (1.11 %) auckland international 130.00 (-3.70 %) axles 162.00 (1.25 %) balmer lawrie 300.00 bharat hotels 162.00 (1.25 %) bima mandi 700.00 bira 91 750.00 (-2.85 %) boat 829.00 (-0.12 %) c & s electric 470.00 (-4.08 %) capgemini 12,100.00 (1.68 %) care health 135.00 (3.85 %) carrier aircon 260.00 (1.96 %) cial 180.00 (-1.64 %) csfbl 265.00 (-3.64 %) csk 170.00 (6.25 %) dalmia refract 81.00 (-4.71 %) dsp merrill lynch 1,000.00 east india pharma 44.00 (2.33 %) eaton fluid 380.00 (1.33 %) electronica plastic 4,100.00 (-4.65 %) elgi ultra 400.00 elofic 1,909.00 (0.47 %) esl steel 39.00 (11.43 %) fincare business 43.00 fincare sfbl 74.00 (1.37 %) fino paytech 160.00 (14.29 %) frick india 3,806.00 (0.16 %) gkn drive 1,240.00 (-0.80 %) go digit gil 354.00 (1.14 %) godavari bio 71.00 (1.43 %) hdbfsl 590.00 (-1.67 %) hdfc ergo 370.00 (1.70 %) hdfc securities 11,200.00 (-2.61 %) hella india 350.00 (6.06 %) hero fincorp 690.00 (-3.36 %) hicks 2,100.00 (-2.55 %) hira ferro 120.00 (-0.83 %) honeywell electrical 3,555.00 (-1.25 %) icex 5.00 (-0.20 %) incred financial 100.00 india carbon 1,010.00 (1.00 %) india exposition 146.00 (0.69 %) indian potash 1,405.00 (0.36 %) indofil 690.00 (-2.82 %) infinite computer 700.00 inkel 12.95 (-0.38 %) ixigo 97.00 (-2.02 %) jana sfbl 75.00 kial 107.00 (-2.73 %) kurlon enterprise 640.00 (-3.03 %) kurlon limited 426.00 (-3.18 %) lava 127.00 (0.79 %) manipal hfsl 72.50 (0.69 %) manjushree tech 970.00 (-3.10 %) martin & harris 1,500.00 (0.33 %) merino 2,770.00 (0.73 %) minosha 280.00 (-3.45 %) mitsubishi heavy 355.00 (1.43 %) mkcl 415.00 (1.22 %) mobikwik 425.00 (-5.56 %) mohan meakin 1,180.00 (-2.64 %) mohfl 10.75 (-9.66 %) msei 0.98 (-2.00 %) msil 56.00 (3.70 %) nayara energy 152.00 (0.66 %) nayara energy ncd 250.00 ncdex 275.00 ncl buildtek 200.00 (2.56 %) ncl holdings 47.50 (1.06 %) nse 3,100.00 (1.64 %) orbis financial 86.00 (1.18 %) oswal minerals 65.00 (1.56 %) otis 3,700.00 (-2.63 %) oyo rooms 69.00 (-2.82 %) panasonic appliances 293.00 (-4.25 %) panasonic avc 29.10 (0.34 %) paymate india 600.00 (-3.38 %) pharma easy 32.00 (-8.57 %) philips domestic 605.00 (0.83 %) philips india 1,100.00 (1.85 %) pnb metlife 70.00 proyuga adtech 25.00 purity flexpack 20.00 ramaraju surgical 490.00 (-2.00 %) rasoi 32,000.00 (3.23 %) reliance gic 340.00 resins plastics 414.00 (1.97 %) ring plus 370.00 (1.37 %) rrl 2,800.00 (-1.75 %) sab miller 303.00 (1.00 %) satya micro 201.00 (0.50 %) scottish assam 500.00 (-3.85 %) shriram life 251.00 (0.40 %) sigachi lab 40.10 (0.25 %) signify 1,100.00 (4.46 %) simpson & company 3,500,000.00 smile micro 52.00 (-1.89 %) sportskeeda 3,303.00 sterlite power 524.00 (0.19 %) studds 950.00 (-0.52 %) svsml 510.00 (-2.30 %) t stanes 675.00 tata capital 56.00 (1.82 %) tata tech 5,400.00 (4.85 %) teesta agro 67.00 (-4.29 %) trl krosaki 1,224.00 (-2.16 %) utkarsh coreinvest 127.00 (-2.31 %) vikram solar 55.50 (-0.89 %) xerox 243.00 (1.25 %)
×

claris life sciences Limited

250.00
+ 0.00 %
Scrip Name
Claris Life Sciences
ISIN No.
INE562G01018
PAN No.
AAACC6366Q
Face Value
10
No. of Outstanding Shares
54,567,765
Market Capitalization
1,364.19 Crore

CLARIS LIFESCIENCES LIMITED DELISTED/UNLISTED SHARES

Founded on 19 July 1994, Claris Lifesciences Limited is a Public Limited Company it is involved in Human Healthcare Activities. It is registered at the registrar of companies in Ahmedabad.  The authorized equity capital of the company is Rs. 1,205,100,030 and the paid-up capital is Rs. 545,677,630.

Shares of Claris Lifesciences Limited were listed on the BSE.  The company's shares stopped trading on BSE on March 15, 2018, and it was delisted from the BSE on March 22, 2018. The exit offer price was Rs. 400 per share for public shareholders.

INCORPORATION DETAILS

CIN

U85110GJ1994PLC022543

Registration Date

19 July 1994

Company Name

Claris Lifesciences Limited

Email Address

-

GST Number

24AAACC6366Q1Z8

Category/Sub-category of the Company

Company Limited by Shares / Non-Government Company

Class of Company

Public

Listing status

Unlisted

Registration Number

22543

Statutory Auditors

Shah & Shah Associates, Ahmedabad

Address of the Registered office & contact details

Claris Corporate Headquarters, Nr. Parimal Railway Crossing, Ellisbridge, Ahmedabad - 380 006, India.

Company Secretary & Compliance Officer

Mr. Kirit H. Kanjaria.

Name, Address & contact details of the Registrar & Transfer Agent, if any

LINK INTIME INDIA PRIVATE LIMITED (Unit: Claris Lifesciences Limited) C-101, 247 Park, L B S Marg, Vikhroli (West), Mumbai - 400 083.

PARTICULAR OF SUBSIDIARY COMPANIES

S. No.

Name of the Company

Subsidiary

% of shares held

 

                                 Foreign Subsidiaries

   

1.

Claris Life Sciences Venezuela C.A.

Subsidiary

100%

2.

PT. Claris Life Sciences Indonesia

Subsidiary

100%

BOARD OF DIRECTORS

Mr. Surrinder Lal Kapur (Chairman  &  Non-Executive and Independent Director)

Mr. Arjun Handa (Vice-Chairman & Managing Director)

Mr. Aditya S. Handa (Non-Executive and Non-Independent Director)

Mr. Chandrasingh S. Purohit (Whole Time Director & CFO)

Mr. Shyamsunder  Sharma (Non-Executive and Non-Independent Director)

Dr. Anup P. Shah (Non-Executive and Independent Director)

 SHAREHOLDING PATTERN (As of 31-03-2021)

S. No.

Shareholder’s Name

No. of Shares

% of total Shares of the company

1

Promoter and Promoters Group

5,41,80,079

99.28%

2

Public

3,87,686

0.72%

 

Total

5,45,67,765

100%

 

 PROFIT & LOSS STATEMENT OF CLARIS LIFESCIENCES LIMITED (Rs. In Lacs) (As of 31-03-2018 to 31-03-2021)

PARTICULARS

2021

2020

2019

2018

INCOME

   

 

 

Other income

4.13

45.92

762.61

1,391.78

Total income

4.13

45.92

762.61

1,391.78

EXPENSES

   

 

 

Finance costs

0.04

0.22

-

-

Other expenses

31.39

145.49

1,246.98

1,793.80

Depreciation and amortization expense

-

-

-

10.31

Total expenses

31.43

145.71

1,246.98

1,804.11

Profit/(Loss) before tax

(27.30)

(99.79)

(484.37)

(412.33)

Tax expense / (benefit)

   

 

 

    Adjustment of tax relating to earlier years

-

(26.92)

-

449.77

    Deferred tax expense

-

428.37

264.70

(278.63)

    Current tax

-

         -

-

-

Total tax expense / (benefit)

-

401.45

264.70

171.14

Profit/(Loss) for the year from continuing operations

-

-

(749.07)

(583.47)

Profit before sharing in loss of Associate and tax from Discontinued operations

-

-

-

3,249.82

Tax Expenses of Discontinued operations

-

-

-

1,110.18

Net Profit / (Loss) for the year from discontinued operations

-

-

-

2,139.64

Profit / (Loss) for the year

(27.30)

(501.24)

(749.07)

1,556.17

Other comprehensive income

   

 

 

Items that will be reclassified to profit and loss

   

 

 

       Exchange differences in translating the financial statements of a

       foreign operation

-

-

41.04

0.08

       Income tax effect on above

-

-

-

-

Total comprehensive income / (loss) for the year

(27.30)

(501.24)

(708.02)

1,556.25

Profit for the year from continuing operations attributable to :

   

 

 

       Owners of the company

-

-

(749.07)

(583.47)

       Non-controlling interest

-

-

-

-

 

-

-

(749.07)

(583.47)

Profit for the year from discontinued operations attributable to :

   

 

 

        Owners of the company

-

-

-

2,283.19

        Non-controlling interest

-

-

-

(143.55)

 

-

-

-

2,139.64

Profit / (Loss) for the year attributable to :

   

 

 

        Equity holders of the parent

(27.30)

(501.24)

-

-

        Owners of the company

-

-

(749.07)

1,699.72

        Non-controlling interest

-

-

-

(143.55)

 

(27.30)

(501.24

(749.07)

1,556.17

Other comprehensive income/(loss) for the year attributable to

   

 

 

        Equity holders of the parent

-

-

-

-

        Owners of the company

-

-

41.04

5.51

        Non-controlling interest

-

-

-

(5.43)

 

-

-

41.04

0.08

Total comprehensive income / (loss) for the year, net of tax

   

 

 

       Equity holders of the parent

(27.30)

(501.24)

-

-

       Owners of the company

-

-

(708.02)

1,705.23

       Non-controlling interest

-

-

-

(148.98)

 

(27.30)

(501.24)

(708.02)

1,556.25

Earnings per equity share of Rs.10 each

   

 

 

      Earnings per equity share (Basic)

(0.05)

(0.92)

-

-

      Earnings per equity share (Diluted)

(0.05)

(0.92)

-

-

      Continuing Operations

-

-

(1.37)

(1.07)

      Discontinued Operations

-

-

-

4.18

Continuing & Discontinued Operations

-

-

(1.37)

3.11

 BALANCE SHEET OF CLARIS LIFESCIENCES LIMITED (Rs. In Lacs) (As of 31-03-2018 to 31-03-2021)

PARTICULARS

2021

2020

2019

2018

ASSETS

   

 

 

Non-current assets

   

 

 

Deferred tax assets (net)

527.85

527.85

956.21

1,220.91

Income tax assets (net)

104.89

104.78

-

-

Non-current tax assets (net)

-

-

634.64

626.74

Property, plant, and equipment

-

-

-

-

Capital work-in-progress

-

-

-

-

Intangible assets

-

-

-

-

Financial assets

   

 

 

     Investments

-

-

-

-

TOTAL

632.74

632.63

1,590.85

1,847.65

Current assets

   

 

 

Financial assets

   

 

 

      Trade receivables

-

-

62.68

58.10

      Cash and cash equivalents

11.63

18.11

27.43

6.88

      Other bank balances

36.02

38.87

38.38

31.60

      Other financial assets

258.76

269.69

341.95

131.62

Other current assets

39.44

39.18

111.98

326.89

TOTAL CURRENT ASSETS

345.85

365.85

582.42

555.09

TOTAL ASSETS

978.59

998.48

2,173.27

2,402.74

EQUITY AND LIABILITIES EQUITY

   

 

 

Equity share capital

5,456.78

5,456.78

5,456.78

5,456.78

Other Equity

(6,622.90)

(6,595.60)

(6,094.36)

(5,386.34)

TOTAL EQUITY

(1,166.12)

(1,138.82)

(637.58)

70.44

LIABILITIES

   

 

 

Current liabilities

   

 

 

Financial liabilities

   

 

 

      Borrowings

2,101.30

2,097.30

-

-

      Trade payables

   

 

 

        Total outstanding dues of micro-enterprises

        and small enterprises

0.54

-

-

-

       Total outstanding dues of creditors other than

       micro-enterprises and small enterprises

34.86

25.04

24.56

192.04

    Other financial liabilities

4.88

12.43

2,783.91

2,003.68

Other current liabilities

3.13

2.53

2.38

136.58

TOTAL CURRENT LIABILITIES

2,144.71

2,137.30

2,810.85

2,332.30

TOTAL EQUITY AND LIABILITIES

978.59

998.48

2,173.27

2,402.74

 

DIVIDEND AND RETAINED EARNINGS (As of 31-03-2018 to 31-03-2019)

Particulars

2021

2020

2019

2018

Dividend

Nil

Nil

Nil

Nil

Retained Earnings (In Rs. Lakhs)

(6,622.90)

(6,595.60)

(6,181.03)

(5,431.96)

 PERFORMANCE OF THE COMPANY

Income decreased from Rs. 45.92 Lacs in FY 2020 to Rs. 4.13 Lacs in FY 2021, showing a decline of 91.01% as compared to the previous financial year.

Finance Cost has decreased from Rs. 0.22 Lacs in FY 2020 to Rs.  0.04 Lacs in FY 2021.

In FY 2021, Company’s Net Loss stood at Rs. 27.30 Lacs,  as against the Rs. 501.24 Lakh loss in FY 2020.

The Current Ratio of the company as of 31st March 2021 was 0.16%.

 The debt-to-equity ratio of the company as of 31st March 2021 was 0.83%.

In the Financial Year 2020-21, the company has not paid dividends.

Annual Reports

2020-21

Download

2019-20

Download

Corporate Actions

Exit offer Claris Life Science dated 16-02-2018

Download

Recent News

Wealth Wisdom - WWIPL
Support Megha Support Neha Support Pallavi